Roche's Genentech has settled a US lawsuit against Indian biopharmaceutical company Biocon over its proposed biosimilar of Genentech's blockbuster breast-cancer drug Perjeta, Biocon said Wednesday.* Biocon said in a ...
New Delhi: Dr Reddy's Laboratories on Tuesday announced the launch of a nivolumab biosimilar, expanding its portfolio of immune-targeting cancer treatments in the country.NIVORZ, a biosimilar to Opdivo (nivolumab), ...
New Delhi, Biocon Ltd on Tuesday said its arm Biocon Biologics has received marketing approval for its pegfilgrastim biosimilar from Japan's Ministry of Health, Labour and Welfare (MHLW).The pegfilgrastim ...
New Delhi: US-based Bristol Myers Squibb (BMS) on Thursday filed a motion in the Supreme Court to prevent Ahmedabad-based Zydus Lifesciences from manufacturing and selling a biosimilar version of ...
New Delhi | Mumbai: The government is giving final touches to a revised set of regulations to set stringent quality standards for research and manufacture of biosimilar drugs, which ...
Biocon Biologics, the subsidiary of Biocon on Saturday has received the USFDA nod to launch the biosimilar version of Janssen's Stelara (Ustekinumab) used for the treatment of autoimmune disorders ...